Reported Earlier, Fennec Pharmaceuticals Prices Offering Of 4,666,667 Common Shares At $7.50 Per Share For ~$35M In Gross Proceeds
Benzinga Newsdesk 11 months ago
NewsOfferings
Fennec intends to use the net proceeds of the offering to repurchase and redeem certain indebtedness and the remaining net proceeds, if any, for working capital and general corporate purposes.
Fennec intends to use the net proceeds of the offering to repurchase and redeem certain indebtedness and the remaining net proceeds, if any, for working capital and general corporate purposes.